ArticleInternational journal of molecular sciences2020
Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling.
Open access · goldAbstract read
In one paragraph
Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 31 citations in OpenAlex.
- Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti-Molecules (Basel, Switzerland) · 2026Article
- From genomes to interventions: computational strategies transforming parasitology.Frontiers in veterinary science · 2026Review
- Protozoan Neglected Tropical Diseases (NTDs) Target Inhibition of Alkaloids fromPharmaceuticals (Basel, Switzerland) · 2025Article
- Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors inPharmaceuticals (Basel, Switzerland) · 2025Article
- Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities.Journal of pharmaceutical analysis · 2025Review
- Identification of novel compounds againstComputational and structural biotechnology journal · 2025Article
- Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole forPharmaceuticals (Basel, Switzerland) · 2024Article
- Nucleoside Analogues for Chagas Disease and Leishmaniasis Therapy: Current Status and Future Perspectives.Molecules (Basel, Switzerland) · 2024Review
- Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents.Molecules (Basel, Switzerland) · 2024Article
- Advances in the Development of Carbonic Anhydrase Inhibitors as New Antiprotozoal Agents.Current medicinal chemistry · 2024Review
- Triose Phosphate Isomerase Structure-Based Virtual Screening and In Vitro Biological Activity of Natural Products asPharmaceutics · 2023Article
- Repurposing of neprilysin inhibitor 'sacubitrilat' as an anti-cancer drug by modulating epigenetic and apoptotic regulators.Scientific reports · 2023Article
- State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation.Research and reports in tropical medicine · 2023Review
- Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities.Frontiers in pharmacology · 2023Review
- An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.Molecules (Basel, Switzerland) · 2021Review
- Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase fromInternational journal of molecular sciences · 2021Article
- Cascade Deep Forest With Heterogeneous Similarity Measures for Drug-Target Interaction Prediction.Frontiers in genetics · 2021Article
- Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning.International journal of molecular sciences · 2020Article
- A Trypsin Inhibitor fromAntibiotics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 3 countries.
Alfredo Juárez-SaldivarLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.ORCID 0000-0002-4059-7361
Michael SchroederBiotechnology Center (BIOTEC), Technische Universität Dresden, 01307 Dresden, Germany.
Sebastian SalentinBiotechnology Center (BIOTEC), Technische Universität Dresden, 01307 Dresden, Germany.
V Joachim HauptBiotechnology Center (BIOTEC), Technische Universität Dresden, 01307 Dresden, Germany.ORCID 0000-0003-0547-1285
Emma SaavedraDepartamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico 14080, Mexico.
Citlali VázquezDepartamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico 14080, Mexico.
Francisco Reyes-EspinosaLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.ORCID 0000-0003-0727-8251
Verónica Herrera-MayorgaLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.ORCID 0000-0002-2267-399X
Juan Carlos Villalobos-RochaLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.
Carlos A García-PérezScientific Computing Research Unit, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Nuria E CampilloCentro de Investigaciones Biológicas (CIB-CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain.
Gildardo RiveraLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.ORCID 0000-0001-9842-4167
Instituto Politécnico Nacional · MXTechnische Universität Dresden · DEInstituto Nacional de Cardiología · MXCentro de Investigaciones Biológicas Margarita Salas · ESHelmholtz Zentrum München · DE
Funding
Consejo Nacional de Ciencia y Tecnologia 282663Instituto Politecnico Nacional SIP-20200491
Abstract
Chagas disease, caused by
Indexed as
Chagas DiseaseComputer SimulationDrug RepositioningFolic Acid AntagonistsGlipizideGlyburideHumansLigandsMolecular Docking SimulationMolecular StructurePyrimidinesStructure-Activity RelationshipSulfonylurea CompoundsTrypanocidal AgentsTrypanosoma cruziFolic Acid AntagonistsGlipizidegliquidoneGlyburideLigandsnilotinibPyrimidinesSulfonylurea CompoundsTrypanocidal Agentsantiprotozoalchagas diseaseFDA-Drugsmolecular dockingprotein-ligand interaction profilerrepositioning
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.